Phase IIA Single-Arm Study of Treatment of Patients with Advanced Liver Cancer with a Combination of TATE (Transarterial Tirapazamine Embolization) Followed by an Anti-PD-1 Monoclonal Antibody

Protocol No
TECLISON-LT-004-TATE-PD1
Phase
II
Summary

This project is being done to test if a new medication named Tirapazamine when injected during embolization can induce tumor death in certain selected tumor lesions and help to boost immunity against other untreated tumor(s).

Description
Combination of TATE and PD-1 Inhibitor in Liver Cancer (TATE-PD1)
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL